1.31
Precedente Chiudi:
$1.31
Aprire:
$1.35
Volume 24 ore:
56,618
Relative Volume:
0.15
Capitalizzazione di mercato:
$11.59M
Reddito:
-
Utile/perdita netta:
$-26.23M
Rapporto P/E:
-1.0673
EPS:
-1.2274
Flusso di cassa netto:
$-10.29M
1 W Prestazione:
-2.99%
1M Prestazione:
-35.96%
6M Prestazione:
-68.29%
1 anno Prestazione:
-92.75%
Seastar Medical Holding Corp Stock (ICU) Company Profile
Nome
Seastar Medical Holding Corp
Settore
Industria
Telefono
844-427-8100
Indirizzo
3513 BRIGHTON BLVD, DENVER
Confronta ICU con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ICU
Seastar Medical Holding Corp
|
1.315 | 11.59M | 0 | -26.23M | -10.29M | -1.2274 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
493.02 | 126.38B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
556.85 | 61.14B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
602.49 | 35.43B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
238.15 | 30.77B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
240.12 | 26.32B | 3.81B | -644.79M | -669.77M | -6.24 |
Seastar Medical Holding Corp Borsa (ICU) Ultime notizie
ICU STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire
ICU stock hits 52-week low at $1.2 amid market challenges - Investing.com
SeaStar Medical gains two new FDA breakthrough designations By Investing.com - Investing.com Australia
SeaStar Medical gains two new FDA breakthrough designations - Investing.com
Major FDA Win: SeaStar's Revolutionary Therapy Targets 45,000 Cardiac Surgery Patients - Stock Titan
Analyzing SeaStar Medical (NASDAQ:ICU) and Solventum (NYSE:SOLV) - Defense World
ICU stock hits 52-week low at $1.5 amid market challenges - Investing.com
SeaStar Medical reports USD 24.8 million loss in FY 2024 - Medical Buyer
Earnings call transcript: SeaStar Medical sees stock dip after Q4 2024 - Investing.com India
SeaStar Medical Holding Corp reports results for the quarter ended December 31Earnings Summary - TradingView
SeaStar Medical Achieves Key Milestones: FDA-Approved Therapy Generates Initial Sales - Stock Titan
SeaStar Medical Holding Corp expected to post a loss of 89 cents a shareEarnings Preview - TradingView
SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025 - The Manila Times
NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award - Quantisnow
Groundbreaking Pediatric Kidney Treatment Earns SeaStar Medical Prestigious NKF Award - Stock Titan
ICU INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Seastar Medical Holding Corp. to Contact the Firm Today! - ACCESS Newswire
SeaStar Medical secures Nasdaq listing extension By Investing.com - Investing.com Australia
SeaStar Medical secures Nasdaq listing extension - Investing.com India
SeaStar Medical’s director John Neuman acquires $153,227 in shares By Investing.com - Investing.com Canada
SeaStar Medical's director John Neuman acquires $153,227 in shares - Investing.com
SeaStar Medical’s director John Neuman acquires $153,227 in shares - Investing.com India
ICU INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SeaStar Medical secures $6 million in direct offering - MSN
SeaStar Medical (NASDAQ:ICU) versus OrthoPediatrics (NASDAQ:KIDS) Financial Review - Armenian Reporter
Contrasting OrthoPediatrics (NASDAQ:KIDS) & SeaStar Medical (NASDAQ:ICU) - Defense World
SeaStar Medical (NASDAQ:ICU) Stock Price Down 1.1% – Here’s Why - Defense World
FINAL ICU DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Seastar Medical Holding Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
ICU Stockholders Have Opportunity to Lead Seastar Medical Holding Corp. Class Action LawsuitContact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
ICU STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire
Quarterly Metrics: Quick and Current Ratios for SeaStar Medical Holding Corp (ICU) - The Dwinnex
How does SeaStar Medical Holding Corp (ICU) change from a tortoise to a hare? - SETE News
SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market - GlobeNewswire
SeaStar Medical Holdings Corporation Enters Into $6 Million Securities Purchase AgreementDENVER (January 31, 2025) – In a move to bolster its financial positioning, SeaStar Medical Holdings Corporation (Nasdaq: ICU) disclosed that it has initiated a - Defense World
SeaStar Medical announces $6M registered direct offering priced ATM - MSN
Investing in SeaStar Medical Holding Corp (ICU): What You Must Know - Knox Daily
Investing in Wimi Hologram Cloud Inc ADR (WIMI) Is Getting More Attractive - Knox Daily
SeaStar Medical Secures $6M Through Equity Agreements - TipRanks
SeaStar Medical Closes $6 Million Registered Direct Offering with Institutional Investor - Nasdaq
Strategic $6M Capital Raise: SeaStar Medical Secures Institutional Backing with Warrant Sweetener - StockTitan
ICU’s earnings forecast for the current quarter - US Post News
ICU Stock: Exploring SeaStar Medical Holding Corp’s Growth - The InvestChronicle
SeaStar Medical receives Nasdaq public reprimand - MSN
SeaStar Medical Holding Co. (NASDAQ:ICUCW) Sees Significant Growth in Short Interest - Defense World
SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market - GlobeNewswire
SeaStar Medical prices 3.53M shares at $1.70 in registered direct offering - TipRanks
SeaStar Medical Raises Fresh Capital: $6M Strategic Investment Fuels Growth Plans - StockTitan
Seastar Medical Holding Corp Azioni (ICU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Seastar Medical Holding Corp Azioni (ICU) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Neuman John | Director |
Jun 17 '24 |
Buy |
4.35 |
10,000 |
43,521 |
20,000 |
Neuman John | Director |
Jun 14 '24 |
Buy |
3.69 |
10,000 |
36,905 |
10,000 |
Neuman John | Director |
Dec 11 '24 |
Buy |
2.04 |
10,000 |
20,405 |
40,000 |
Chung Kevin | Chief Medical Officer |
Nov 18 '24 |
Buy |
1.99 |
4,250 |
8,458 |
13,685 |
Chung Kevin | Chief Medical Officer |
Sep 30 '24 |
Buy |
4.26 |
1,000 |
4,258 |
9,435 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):